Duration of Follow Up for New Molecular Entities Approved in 2011

    Basic Details
    Date Posted
    Friday, April 16, 2021
    Status
    Complete
    Medical Product
    new molecular entities (NMEs)
    Description

    In this report we described baseline characteristics and the duration of follow-up time among new users of 30 new molecular entities (NMEs) approved in 2011 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).